細(xì)胞因子Recombinant Human CD22|重組人CD22蛋白
產(chǎn)品名稱: 細(xì)胞因子Recombinant Human CD22|重組人CD22蛋白
產(chǎn)品型號(hào): C02-100-01
產(chǎn)品展商: peprotech
產(chǎn)品文檔: 無相關(guān)文檔
簡單介紹
細(xì)胞因子Recombinant Human CD22|重組人CD22蛋白系列產(chǎn)品主要適用于試驗(yàn)室或生化科研相關(guān)試驗(yàn)，CANSPEC品質(zhì)提供的細(xì)胞因子Recombinant Human CD22|重組人CD22蛋白性能**，中文名稱為重組人CD22蛋白。產(chǎn)品人細(xì)胞因子CD22|Human CD22以其優(yōu)良的品質(zhì)滿足您不同科研實(shí)驗(yàn)的多種需求。
細(xì)胞因子Recombinant Human CD22|重組人CD22蛋白
的詳細(xì)介紹
產(chǎn)品名稱：細(xì)胞因子Recombinant Human CD22|重組人CD22蛋白
產(chǎn)品規(guī)格：
| C02-100-01-100ug |
人細(xì)胞因子CD22|Human CD22 |
100ug |
￥11,900 |
| C02-100-01-1mg |
人細(xì)胞因子CD22|Human CD22 |
1mg |
￥67,200 |
| C02-100-01-20ug |
人細(xì)胞因子CD22|Human CD22 |
20ug |
￥1,960 |
| C02-100-01-500ug |
人細(xì)胞因子CD22|Human CD22 |
500ug |
￥40,320 |
| C02-100-01-5ug |
人細(xì)胞因子CD22|Human CD22 |
5ug |
￥680 |
單 位：瓶
關(guān) 鍵 字：Recombinant Human CD22|重組人CD22蛋白
CANSPEC品質(zhì)提供的人細(xì)胞因子CD22|Human CD22性能**，英文名稱人細(xì)胞因子CD22|Human CD22，簡稱為人細(xì)胞因子CD22|Human CD22，中文名稱為人細(xì)胞因子CD22|Human CD22。
產(chǎn)品人細(xì)胞因子CD22|Human CD22以其優(yōu)良的品質(zhì)滿足您不同實(shí)驗(yàn)的多種需求。并保證每批人細(xì)胞因子CD22|Human CD22的質(zhì)量和人細(xì)胞因子CD22|Human CD22品質(zhì)優(yōu)良。
|
Description :
|
CD22 is a B-lineage restricted 135 kDa glycoprotein whose cell surface expression is limited to resting and activated B lymphocytes. The physiological role of CD22 is still unknown. Targeted disruption of CD22 in mice results in a reduced level of surface IgM on peripheral B cells suggesting a role for CD22 in limiting antigen receptor signaling. CD22 is a member of the Ig gene superfamily that uniquely binds a sialic acid-dependent ligand. Recombinant human CD22 is a soluble 75.0 kDa protein which corresponds to the extracellular domain of CD22.
|
|
Catalog #:
|
100-01
|
|
Source :
|
CHO cells
|
|
Stability :
|
The lyophilized protein is stable for at least 2 years from date of receipt at -200C. Reconstituted CD22 is stable for at least 3 months when stored in working aliquots with a carrier protein at -200C. Avoid repeated freeze/thaw cycles.
|
|
Purity :
|
Greater than 98% by SDS-PAGE gel and HPLC analyses.
|
|
Endotoxin Level :
|
Endotoxin level is less than 0.1 ng per µg (1EU/µg).
|
|
Biological Activity :
|
Determined by its ability to inhibit the proliferation of Raji cells. The expected ED50 for this effect is 10-17 μg/ml.
|
|
AA Sequence :
|
SKWVFEHPET LYAWEGACVW IPCTYRALDG DLESFILFHN PEYNKNTSKF DGTRLYESTK DGKVPSEQKR VQFLGDKNKN CTLSIHPVHL NDSGQLGLRM ESKTEKWMER IHLNVSERPF PPHIQLPPEI QESQEVTLTC LLNFSCYGYP IQLQWLLEGV PMRQAAVTST SLTIKSVFTR SELKFSPQWS HHGKIVTCQL QDADGKFLSN DTVQLNVKHT PKLEIKVTPS DAIVREGDSV TMTCEVSSSN PEYTTVSWLK DGTSLKKQNT FTLNLREVTK DQSGKYCCQV SNDVGPGRSE EVFLQVQYAP EPSTVQILHS PAVEGSQVEF LCMSLANPLP TNYTWYHNGK EMQGRTEEKV HIPKILPWHA GTYSCVAENI LGTGQRGPGA ELDVQYPPKK VTTVIQNPMP IREGDTVTLS CNYNSSNPSV TRYEWKPHGA WEEPSLGVLK IQNVGWDNTT IACARCNSWC SWASPVALNV QYAPRDVRVR KIKPLSEIHS GNSVSLQCDF SSSHPKEVQF FWEKNGRLLG KESQLNFDSI SPEDAGSYSC WVNNSIGQTA SKAWTLEVLY APRRLRVSMS PGDQVMEGKS ATLTCESDAN PPVSHYTWFD WNNQSLPHHS QKLRLEPVKV QHSGAYWCQG TNSVGKGRSP LSTLTVYYSP ETIGRR
|
|
PubMed Link :
|
CD22
|
